Actively Recruiting

Age: 18Years - 100Years
All Genders
NCT05963126

Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients

Led by University Hospital Ostrava · Updated on 2023-07-27

200

Participants Needed

1

Research Sites

182 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Commonly used parameters (creatinine, estimated glomerular filtration rate, and urine albumin/creatinine ratio) for prediction of decline of renal function are sensitive for advanced kidney impairment. Modified human urine Fetuin A (urine Fetuin A) with specific modification in urine (Fetuin A) can earlier predict the progression of kidney disease in patients with diabetes. Studies evaluating urine Fetuin A in hypertonic patients are still lacking.

CONDITIONS

Official Title

Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have arterial hypertension treated with at least one antihypertensive medication
Not Eligible

You will not qualify if you...

  • Have diabetes mellitus of any type, defined as fasting glucose >7.0 mmol/l or any glycemia >11.0 mmol/l, or HbA1c >48 mmol/mol
  • Have decompensated arterial hypertension defined as office blood pressure >180/110 mmHg or on Ambulatory Blood Pressure Monitoring
  • Are receiving renal replacement therapy
  • Have rheumatoid diseases such as rheumatoid arthritis, systemic lupus, scleroderma, dermatomyositis, or inflammatory bowel disease, or test positive for antinuclear antibody or extractable nuclear antigen
  • Have an acute infection with C-Reactive Protein >50 mg/l
  • Have severe liver impairment such as cirrhosis or elevated liver enzymes (ALT or AST >10 μkat/l)
  • Have a terminal incurable illness

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Ostrava, - Department of Internal Medicine and Cardiology

Ostrava, Czech Republic, Czechia, 70852

Actively Recruiting

Loading map...

Research Team

J

Jiří Hynčica

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here